Home » Headlines » Currently Reading:

Morning Headlines 11/20/12

November 19, 2012 Headlines No Comments

NextGen Healthcare Launches New 8 Series Electronic Health Record (EHR) Content

NextGen releases its newest platform, dubbed 8 Series, which promises a faster and easier clinical user experience.

Medical education provider Pri-Med buys Amazing Charts, an electronic health records firm

Pri-Med, a Boston-based medical education firm, buys EHR vendor Amazing charts for an undisclosed sum.

National Football League Selects eClinicalWorks

The NFL has announced it will implement a league-wide eClinicalWorks EHR to better manage player injuries.

The Patient Engagement Framework

The National eHealth Collaborative publishes a five-tier framework for strengthening patient engagement strategies.

McKesson Announces $1 Million Software Give-Away to Help Benevolent Physicians Bring Better Health to Patients Across America

McKesson will donate more than $1 million in free EHR licenses to physicians providing charity care to the needy.



HIStalk Featured Sponsors

     

Text Ads


RECENT COMMENTS

  1. Wayne Gillis' LinkedIn post. Neither Rehoboth McKinley or Great Falls Clinic is on Epic. Did he miss a workplace on…

  2. Good DTC discussion a few weeks ago on LinkedIn: https://www.linkedin.com/posts/graham-walker-md_what-if-we-made-a-lot-more-tests-direct-to-consumer-activity-7426998007272861697-ZCGP?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAGYl5gBhHG9z_iLVKPFLIJzVxbfDeN79Is Also distinctions between DTC and Direct Access Testing (DAT): https://myadlm.org/cln/cln-daily/2023/direct-to-consumer-laboratory-testing…

  3. The link to Wayne Gillis' post doesn't seem to work, though I did find it through searching directly in LinkedIn.…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.